Delivery Order SPE2DB25D3003-SPE2DB25FPVMH

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has a ceiling value of $5,586.06 and is set to expire on November 22, 2024. The contract is a firm fixed price delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR medication. The contract is a firm-fixed-price delivery order with a ceiling value of $5,779.12 and an ultimate completion date of December 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of BENLYSTA 200 mg/ml autoinjector medication. The contract has a ceiling value of $11,172.12 and a period of performance through September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $6,165.34 and a period of performance through January 27, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract has a firm-fixed price of $2,793.03 and a completion date of November 20, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract is a firm fixed price award with a ceiling value of $11,172.12 and a period of performance through September 30, 2024. This delivery order is a part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued up to $999,999,999, which allows the agency to procure a comprehensive range of pharmaceutical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, with a ceiling value of $3,082.67 and a completion date of January 27, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug BENLYSTA 200 MG/ML AUTOINJECTML. The contract is a firm fixed-price delivery order with a ceiling value of $5,402.70 and a completion date of June 7, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR. The contract has a firm fixed price ceiling value of $5,586.06 and an ultimate completion date of August 27, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this order as part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025 for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of BENLYSTA 200 mg/mL autoinjectors. The contract has a total ceiling value of $5,586.06 and a period of performance through July 16, 2024. The contract is a firm-fixed-price, delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery...
  • SPE2DB25D3003
    Indefinite Delivery Contract
  • SPE2DB25D3003-SPE2DB25FPVMH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The contract is a firm fixed-price delivery order with a ceiling value of $6,165.34 and a period of performance through January 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 10:43 AM